Breaking News

How Boston Medical Center’s health equity accelerator is fast-tracking clinical improvements

Not rendering correctly? View this email as a web page here.

How the agile in pharma trend is transforming drug development [Sponsored]

By Stephanie Baum Wednesday, July 6, 2022 7:30 AM

Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

Read more »

CureVac sues BioNTech, claiming Covid-19 vaccine infringes key mRNA patents

By Frank Vinluan Tuesday, July 5, 2022 5:03 PM

Messenger RNA vaccine biotech CureVac is suing BioNTech, alleging that its rival's Covid-19 vaccine infringes on intellectual property built on more than two decades of research. BioNTech responded that its work is original and the company will defend against the infringement allegations.

Read more »

Healthcare leaders are optimistic about metaverse disruption, report says

By Katie Adams Tuesday, July 5, 2022 3:41 PM

The metaverse has significant potential to disrupt traditional healthcare delivery in the long term, according to a recent Accenture report. While it will likely take time for providers to begin building their own digital environments in the metaverse, healthcare leaders said they believe metaverse technologies will have a positive impact on healthcare.

Read more »

AstraZeneca broadens its scope in blood cancers with $100M TeneoTwo buyout

By Frank Vinluan Tuesday, July 5, 2022 1:00 PM

AstraZeneca is acquiring TeneoTwo in a $100 million bet on that biotech's lymphoma drug candidate, which is designed to go after two targets. It's the latest deal made by a big pharmaceutical company looking to get its hands on a new type of cancer therapy called a T cell engager.

Read more »

   

No comments